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Myofibrillogenesis regulator-1 (MR-1) is a gene overexpressed usually in many human cancers. However, the effects of MR-1 on 
cell proliferation, adhesion, migration and genome-wide gene regulation are still unclear. In this study, a human hepatoma cell 
line that highly overexpresses MR-1, BEL-7402/MR-1 cells was established. While the high expression of MR-1 did not promote 
cell proliferation, it significantly increased cell spreading, adhesion and migration compared with control cells. A total of 147 
genes were regulated by MR-1 expression, 46 genes were down-regulated and 101 genes were up-regulated by MR-1 overexpres-
sion. Many of these genes were related to cell adhesion, cytoskeletal regulation, MAPK signaling, and cell cycle related pathways. 
Western blot analysis further confirmed the regulation of pathways associated with migration by MR-1. These results suggest that 
MR-1 is involved in the regulation of cancer cell adhesion, migration and related gene expression.  
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Cancer metastasis is a highly complex process involving 
several steps: (1) loss of cellular adhesion, (2) increased 
motility and invasiveness, (3) intravasation and survival in 
the circulation, (4) extravasation into new tissue, and (5) 
eventual colonization of the distal site [1,2]. Cancer cell 
migration plays a key role in tumor metastasis and involves 
several different processes that are regulated by various 
signaling molecules [3]. Recent advances in the molecular 
profiling of cancer using genomic-level approaches have 
revealed many metastasis-related genes, and prompted a 
reconsideration of how, where, and when cancer cells ac-
quire genes relevant to metastasis [4]. 
Myofibrillogenesis regulator-1 (MR-1), a new gene in-
volved in metastasis, maps to 2q35 and was first cloned 
from a human cDNA library (GenBank accession number 
AF417001) [5,6]. MR-1 is overexpressed in many human 
cancers including liver, breast, colon, fibrosarcoma, lung, 
ovarian [7] and lymphoma (data not published). Chemo-
therapeutic treatment has been shown to repress the expres-
sion of MR-1 in cancer cells [7]. Further, knockdown of 
MR-1 by siRNA in hepatic carcinoma HepG2 cells de-
creased cell proliferation, adhesion and invasion [8]. Some 
of the genes and signaling pathways regulated by MR-1 
have been identified, such as Myosin light chain 2 (MLC-2), 
MAPK, FAK/Akt pathway [8], and NF-κB [9]. However, 
the gene expression profiles on a genomic level have yet to 
be determined. 
Previously, we have knocked down MR-1 in human he-
patoma HepG2 cells using RNAi and found that cell prolif-
eration and migration were blocked both in vitro and in vivo. 
MR-1 was found to activate MLC-2 though phosphorylation 
of Ser-19, subsequently stimulating stress fiber formation 
and activation of the FAK/Akt signaling pathway [8]. It has 
also been shown that knockdown of MR-1 inhibited cell pro-
liferation in another human hepatoma cell line, BEL-7402 
[10]. 
In this study, we have used BEL-7402 cells and estab-
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lished a stable cell line overexpressing MR-1 (BEL-7402/ 
MR-1). We have investigated the effect of high MR-1 ex-
pression on cell adhesion and migration. Furthermore, we 
performed a microarray assay to analyze changes in gene 
expression profiles caused by MR-1 overexpression or 
knockdown to better understand the molecular alterations 
associated with MR-1 activity. 
1  Materials and methods 
1.1  Cell culture and reagents 
Human hepatoma BEL-7402 cells were purchased from the 
Institute of Biochemistry and Cell Biology (Shanghai, China), 
and grown in RPMI-1640 (Hyclone, Utah, USA) supple-
mented with 10% fetal bovine serum (FBS) (Tianjing Hao 
Hai Biomaterial Technology Company, China), penicil-
lin-streptomycin (100 U/mL), and 2 mmol/L L-glutamine. 
Lipofectamine™2000 and RNAiMAX were from Invitro-
gen Life Technologies (Carlsbad, CA, USA), anti--actin 
(sc-1616), horseradish peroxidase-conjugated goat anti-rab-     
bit (ZB-2301) or rabbit anti-goat (ZB-2306) secondary an-
tibodies were from Santa Cruz Biotechnologies (Santa Cruz, 
CA, USA). Rabbit anti-MR-1 polyclonal antibody was a 
kind gift from Dr. Yiguang Wang. Fibronectin, Cy3- dCTP 
and Cy5-dCTP were from Pharmacia (Stockholm, Sweden). 
Twenty-two thousand human genomic microarrays were 
from CapitalBio (Beijing, China). 
1.2  Plasmid construction 
DNA primers for MR-1 were synthesized by Sai Bai Sheng 
Co. (Beijing, China) as follows; MR1a: 5′-ATTAGGATCC-     
ATGGCGGCGGTGGTAGCTGCT-3′ and MR1b: 5′-ATTA-     
GAATTCTCAGGTCTGCACCCCAGACCC-3′. These pri-
mers were used to amplify full-length MR-1 from human 
hepatoma HepG2 cells using PCR. The amplified product 
was the subcloned into the BamHI-EcoRI sites in pCDNA3.1 
(ClonTech, CA, USA).  
1.3  Plasmid transfection 
Cells were cultured in 10% FBS medium without antibiotics 
18−20 h before transfection. Once cells reached 90% con-
fluency, they were transfected with either MR-1 or vector 
alone (to generate the negative control BEL-7402/EV cells) 
with Lipofectamine 2000 according to the manufacturer’s 
instructions. Six hours after transfection, the medium was 
replaced using 10% FBS medium without antibiotics. 
1.4  siRNA and transfection 
siRNAs were bought from RiBoBio Co. (Guangzhou, China) 
with the following sequences: mock-siRNA: 5′-UUCUCC-   
GAACGUGUCACGUdTdT-3′ and MR-1-siRNA: 5′-CCU-     
AGGCUAUUGACUGUUAdTdT-3′. Cells were trypsinized 
and seeded to 6- well plate with appropriate concentration 
in fresh medium without antibiotics. After 18−20 h, when 
reached 30%–50% confluency. Cells were transfected with 
the siRNAs using Lipofectamine RNAiMAX according to 
the manufacturer’s instructions. 
1.5  Stable transfection of MR-1 
After transfected with pCDNA3.1-MR-1 for 24 h, the cells 
were cultured in selection media (containing 400 g/mL 
G418) for 2 weeks until all non-transfected cells had died. 
The remaining cells were then trypsinized, counted, and 
diluted to 5 cells/mL in a volume of 100 L per well in 
96-well plate. Those wells that contained only one cell were 
cultured until confluent, and then transferred sequentially to 
a 24-well plate, a 6-well plate and finally a 25-mL flask.  
1.6  Cell proliferation and colony formation 
To measure cell proliferation, cells were seeded at a density 
of 1000 per well in 24-well plates. The medium was changed 
daily, and cells were counted every 24 h for 7 d. To assay 
colony formation, cells were seeded at a density of 100 per 
well in 24-well plates. Culture medium was changed every 
4 d and colonies were stained with hematoxylin, photo-
graphed and counted after 7 d. Colony formation=number 
of colonies/number of cells seeded×100%. 
1.7  Western blotting  
Transfected cells were lysed in 100 L RIPA lysis buffer 
(50 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, 1% 
NP-40, 1 mg/mL leupeptin, 1 mg/mL aprotinin, 1 mmol/L 
NaF, 1 mmol/L Na3VO4) at 4°C for 30 min. Then centri-
fuged the tubes at 12000×g for 20 min at 4°C and saved the 
supernatant. Protein concentration was determined by the 
Bradford assay. Equal amount of lysate (40 g) was used to 
run SDS-polyacrylamide gel and transferred to polyvinyli-
dene fluoride (PVDF) membrane (Millipore, Bedford, MA, 
USA). Then block the membranes with 5% non-fat milk in 
TBS-T buffer (20 mmol/L Tris-HCl, NaCl 0.9%(w/v), 0.1% 
Tween-20) at 25°C for 1 h and incubated with primary an-
tibodies for 2 h. Appropriate horseradish peroxidase-linked 
secondary antibodys were then used for 1 h membrane in-
cubation. After that the membranes were incubate with ECL 
reagents (Millipore) and took photoes with a ChemiImager 
5500 imaging system (Alpha Innotech Corporation, San 
Leandro, CA, USA). 
1.8  Cell adhesion assay 
A 96-well plate was coated with 10 g/mL fibronectin 
(FN)(MERKE, Germany) for 1 h and then blocked with   
1 g/mL bovine serum albumin (BSA) for 1 h. Cells were 
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trypsinized, counted, and washed in serum-free RPMI1640 
medium and then resuspended in culture medium. Then 100 
μL of suspended cells was added to each well of the wells 
and then incubated for 15, 30, 60 or 90 min at 37°C in a 
CO2 incubator. Cells that had been attached for 10 h were 
used as a negative control. Attached cells were analyzed by 
MTT assay after non-adherent cells were removed by 
washing with PBS as described previously [8]. Adhesion 
rate=(A570 adherent cells/A570 control cells)×100%. 
1.9  Analysis of cell spreading morphology 
Cells were trypsinized, counted, suspended in serum-free 
RPMI1640 medium, and then seeded on 10 g/mL FN- 
coated 96-well plates for 30, 60 and 120 min at 37°C. They 
were then photographed using a Nikon upright scope 
equipped with a camera (Eclipse TE2000-U, Nikon, Japan). 
1.10  Wound-healing and cell migration assays 
Cells were seeded in 24-well plates and grown in growth 
medium to near confluence, and carefully draw a linear 
“wound” in the cell monolayer of each well using a plastic 
pipette tip scratched. Then washed with phosphate-buffered 
saline (PBS) twicely to remove detached cells and debris 
from the monolayer. The plates were monitored by an 
Eclipse TE2000-U image analysis system after 24 and 48 h. 
The wounded area was measured and quantified (Image 
Pro-Plus software) as wound closure and reported as per-
centage wound healing using the following equation: % 
wound healing=[1(wound area at t24/48 h/wound area at t0)] 
×100, where t0 is the time immediately after wounding. For 
cell migration assays, cells were suspended in serum-free 
RPMI1640 medium containing 0.1% BSA were applied to 
the upper chamber of a Transwell plate (Costar, Cambridge, 
MA, USA). RPMI1640 containing 20% FBS and 10 g/mL 
FN was added to the lower chamber. After incubation at 
37°C for 3 h, cells that had migrated to the lower chamber 
and were stained with hematoxylin, and counted as cells per 
microscopic field (400× magnification).  
1.11  RNA extraction and microarray analysis 
Total RNA was extracted using TRIzol reagent (Invitrogen) 
and purified with NucleoSpin RNA clean-up kit (Ma-
cherey-Nagel, Germany). RNA were labeled with Cy3 and 
Cy5 using a cRNA labeling method following the protocol 
from CapitalBio (Beijing, China). Briefly, the dou-
ble-stranded cDNAs were synthesized using T7-Oligo (dT)15 
(5′-AAACGACGGCCAGTGAATTGTAATACGACTCAC-     
TATAGGCGCTTTTTTTTTTTTTTTTG-3′) primers. cRNA 
was then generated by in vitro transcription. Reverse tran-
scription was then performed using nine base (N9) random 
primers. The products of the reverse transcription reaction 
were labeled with Cy3 and Cy5 using KLENOW and N9  
random primers. Fluorescence exchange was done to elimi-
nate false positive and negative signals. Labeled DNA was 
hybridized with the microarrays at 42°C overnight. After 
hybridization and subsequent washing, the arrays were ana-
lyzed with a LuxScan 10K/A dual channel laser scanner 
(CapitalBio). Data were normalized using Lowess method, 
and only those genes with consistent alteration tendency 
(both >1.5-fold) in both microarrays were choosed as dif-
ferentially expressed genes. Gene function and pathway 
analysis was finished by Pathway Miner (http://www.bio-      
rag.org/) and DAVID Bioinformatics Resources (The Data-
base for Annotation, Visualization and Integrated Discovery). 
2  Results 
2.1  Establishment of MR-1 stable high-expressing cells 
BEL-7402/MR-1 
MR-1 was successfully cloned into the plasmid pcDNA3.1 
and named pcDNA3.1-MR-1. This vector could generate 
full-length MR-1 protein stably and effectively. After stable 
transfection of pcDNA3.1-MR-1 into human hepatocellular 
carcinoma BEL-7402 cells, the levels of MR-1 were signif-
icantly increased (Figure 1). Stably transfected clone #1 was 
selected and named BEL-7402/MR-1 for the remaining ex-
periments. Another clone from cells stably transfected with 
the control vector pcDNA3.1 was randomly selected and 
named BEL-7402/EV as a negative control. 
2.2  Overexpression of MR-1 did not promote cell pro-
liferation 
Cell growth curves and colony formation assays were used 
to analyze the ability of MR-1 to regulate cell growth and 
colony formation of BEL-7402 cells. We found no signifi-
cant difference in cell growth or colony formation among 
BEL-7402, BEL-7402/EV and BEL-7402/MR-1 cells (Fig-
ure 2).  
2.3  MR-1 increased cell spreading 
To test cell spreading efficiency, BEL-7402, BEL-7402/EV 
and BEL-7402/MR-1 cells were plated on FN-coated cell 
culture dishes (Figure 3). BEL-7402/MR-1 cells began to 
spread on FN-coated culture plates 60 min after seeding,  
 
Figure 1  MR-1 was highly expressed in human hepatoma BEL-7402/ 
MR-1 cells as detected by Western blot analysis. 
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Figure 2  MR-1 did not significantly affect cell growth (a) and colony formation (b).  
 
Figure 3  Cell spreading was increased in BEL-7402/MR-1 cells.  
while most of the BEL-7402 and BEL-7402/EV cells still 
remained rounded. After 120 min, most of the BEL-7402/ 
MR-1 cells were much better spread compared with BEL- 
7402 and BEL-7402/EV cells. These data indicated that 
MR-1 could enhance the spreading ability of BEL-7402 cells. 
2.4  MR-1 increased cell adhesion 
Cell adhesion to the extracellular matrix is a key step in 
invasion and metastasis. As shown in Figure 4, compare 
with BEL-7402 and BEL-7402/EV cells, the cell adhesion 
to FN of BEL-7402/MR-1 cells was significantly higher. 
2.5  MR-1 increased cell migration 
Wound-healing and Transwell culture assays were used to 
analyze the ability of MR-1 to regulate cell migration. 
Wound-healing assay showed that BEL-7402/MR-1 cells, 
but not BEL-7402 and BEL-7402/EV cells, began to mi-
grate into the scratched wound after 24 h. After 48 h, BEL- 
7402/MR-1 cells migration into the scratched area was 
much more evident compared with BEL-7402/EV and BEL- 
7402 cells. Wound healing analysis showed that after 48 h, 
BEL-7402/MR-1 cells had covered approximately 80% of 
the scratched wound, which is significantly higher than ei-
ther the BEL-7402/EV (53%) or BEL-7402 cells (45%) 
(Figure 5(a)). 
In Transwell culture systems, cells can migrate through a 
porous membrane when high concentrations of serum are 
presented as a chemotactic factor. In this assay, BEL-7402/ 
MR-1 cells showed significantly increased chemotaxis 
(29.7% more) compared with BEL-7402 cells (Figure 5(b)) 
(P<0.05). This indicated that MR-1 could enhance the 
chemotactic migration of BEL-7402 cells.  
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Figure 4  Cell adhesion to FN was increased in BEL-7402/MR-1 cells.   
* P<0.05.  
2.6  MR-1 altered the gene expression profile in BEL- 
7402/MR-1 cells 
To analyze the genome-wide alteration gene expression,  
total RNA was extracted from BEL-7402/EV and BEL-7402/ 
MR-1 cells for microarray experiments. For our analysis, an 
alteration of 1.5-fold signal intensity was regarded as a sig-
nificant change in mRNA expression, and 338 genes were 
up-regulated and 980 genes were down-regulated in BEL- 
7402/MR-1 cells compared with BEL-7402/EV cells (data 
not shown).  
In addition to analyzing the effects of MR-1 overexpres-
sion, we also analyzed the effects of MR-1 knockdown   
on gene expression in BEL-7402 cells. Genes with signifi-
cantly changed expression levels were clustered using a hier-
archical average linkage clustering program for MR-1 siR-
NA treated cells (As described previously [8], siRNA effi-
ciently reduced the expression of MR-1, data not shown) 
(Figure 6). We found a total of 249 genes affected by both 
MR-1 overexpression and knockdown which we divided 
into four clusters. In Cluster 1, 101 genes were up-regulated 
in BEL-7402/MR-1 cells and down-regulated in MR-1 siR-
NA-treated cells. By contrast, in Cluster 4, we identified 47 
genes that were down-regulated in BEL-7402/MR-1 cells 
and up-regulated in MR-1 siRNA-treated cells.  
We used a gene functional enrichment analysis using 
DAVID Bioinformatics Resources [10,11] to further char-
acterize the genes affected by MR-1 expression (Clusters 1  
 
Figure 5  Cell migration was increased in BEL- 
7402/MR-1 cells as measured by wound-healing (a) 
and Transwell migration assays (b). Cell numbers 
were counted under the microscope after hematox-
ylin staining. * P<0.05. 
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Figure 6  Cluster analysis of gene expression changes measured by mi-
croarray analysis. Red: increase in gene expression; green: decrease in 
gene expression. 
and 4). We showed that the up-regulated genes are enriched 
in tumor-related functions, including cell-cell signaling, cell 
proliferation, cell differentiation, cell survival, and cell ad-
hesion (Table 1). These genes have also been shown to be 
enriched by other conditions, including stress and drug re-
sponse (data not shown).  
We choose genes in the Kyoto Encyclopedia of Gene and 
Genomes (KEGG) database which had higher expression 
levels and had a crucial role in migration to further validate 
the protein expression levels of these genes. We demon-
strated that the expression levels of FN1, SDC2 and ITGA5 
were up-regulated in BEL-7402/MR-1 cells compared with 
BEL-7402/EV and BEL-7402 cells (Figure 7). This suggests 
that the enhancement of cell migration in BEL-7402/MR-1 
cells might be partly regulated by the up-regulation of these 
proteins.  
Pathway analysis was done using a network platform, 
Pathway miner. In this platform, after uploading genes and 
their changed ratio values, their related pathways are indi-
cated. The analysis of signaling pathways by the KEGG 
database showed that MR-1 affect pathways related to cell 
adhesion, cytoskeletal regulation, cytokine interactions, and  
 
Figure 7  The expression levels of proteins related to migration measured 
by Western blot analysis. 
Table 1  Enrichment analysis of gene function regulated by MR-1 
Gene type affected by MR-1 Gene function P-value 
Up-regulated genes 
Cell proliferation 0.021 
Cell differentiation 0.022 
Cell survival 0.022 
Cell adhesion 0.040 
Cell motility 0.079 
Down-regulated genes Cell cycle 0.037 
 
cell cycle signal transduction pathway. This analysis indicated 
that MR-1 might play a role in tumor metastasis and inva-
sion (Table 2), consistent with the above experimental results.  
3  Discussion 
During the process of cancer metastasis, cancer cells invade 
into the surrounding normal tissue. It was found that prior to 
invasion; some highly mobile cells with elevated levels of 
ERK1/2 activity already existed in pre-invasive tumors [12]. 
Therefore, the molecular control of cell migration may be 
an important issue for cancer therapy [13]. Tumor cell mi-
gration is a complex process and is regulated by many sig-
naling molecules, such as focal adhesion kinase (FAK) that 
regulates cell-matrix adhesion, and myosin light chain ki-
nase (MLCK) or Rho-related coiled-coil forming protein ki-
nase (ROCK) that regulate cell migration by promoting myo-
sin II contraction [14−16]. MR-1 is a novel protein discov-
ered by Wang and colleagues that can stimulate the phos-
phorylation of MLC-2, affect cell-matrix adhesion through 
MLC-2/FAK/Akt pathways, and regulate cell migration and 
proliferation [8]. To further elucidate the role of MR-1, we 
generated human hepatoma cells that stably overexpress 
MR-1, BEL-7402/MR-1 cells. We analyzed the effects of high  
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Gene description BEL-7402/MR-1  
vs. BEL-7402 
MR-1 siRNA vs. 
Mock siRNA 
Focal adhesion 
FN1 17.73 0.16 Fibronectin 1 
VAV2 1.55 0.17 
Homo sapiens vav 2 oncogene (Rho GTPases guanine nucleotide ex-
change factor) 
ITGA5 1.51 0.62 Integrin 5 (fibronectin receptor alpha subunit) 
MET 1.83 0.13 Met oncogene (hepatocyte growth receptor factor receptor) 
MAPK3 0.57 1.68 Mitogen-activated protein kinase 3 
ECM-receptor interaction 
FN1 17.73 0.16 Fibronectin 1 
SDC2 3.63 0.66 Syndecan 2 (heparan sulfate proteoglycan 1, fibroglycan) 
ITGA5 1.51 0.62 Integrin 5 (fibronectin receptor alpha subunit) 
FNDC3 1.72 0.32 Fibronectin type III domain 
Regulation of actin cyto-
skeleton 
FN1 17.73 0.16 Fibronectin 1 
VAV2 1.55 0.17 
Homo sapiens vav 2 oncogene (Rho GTPases guanine nucleotide ex-
change factor) 
ITGA5 1.51 0.62 Integrin 5 (fibronectin receptor alpha subunit) 
ARPC1A 1.51 0.53 Actin related protein 2/3 complex, subunit 1A 
MAPK3 0.57 1.68 Mitogen-activated protein kinase 3 
Cytokine-cytokine recep-
tor interaction 
BMP2 1.89 0.25 Bone morphogenetic protein 2 
OSMR 2.57 0.38 Oncostatin M Receptor 
TGFBR2 1.80 0.24 Transforming growth factor  receptor II 
MET 1.83 0.13 Met oncogene (hepatocyte growth receptor factor receptor) 
Wnt signaling pathway 
WNT6 5.78 0.24 Wingless-type MMTV integration site family, member 6 
WNT5A 3.86 0.39 Wingless-type MMTV integration site family, member 5A 
Cell cycle 
CDKN1C 1.82 0.36 Cyclin-dependent kinase inhibitor 1C (p57, Kip2) 
PKMYT1 0.62 2.08 
Membrane-associated tyrosine- and threonine- specific cdc2-inhibitory 
kinase 
CCNB1 0.55 1.98 Cyclin B1 
MAPK signaling pathway 
DUSP4 3.14 0.55 Dual specificity protein phosphatase 4 
TGFBR2 1.80 0.24 Transforming growth factor  receptor II 
MAPK3 0.57 1.68 Mitogen-activated protein kinase 3 
 
expression of MR-1 on proliferation, colony formation, ad-
hesion, migration as well as genome-wide mRNA expression.  
Cell proliferation and colony formation assays showed 
the proliferative ability of BEL-7402/MR-1 cells was not 
higher than controls, BEL-7402 and BEL-7402/EV cells. 
However, previous studies have shown that cell prolifera-
tion was significantly reduced after MR-1 was knocked 
down by RNAi in BEL-7402 and HepG2 cells [10]. This 
might a result of the complex regulation of signaling path-
ways related to proliferation—overexpression of MR-1 in 
cells whose MR-1 level are already highly expressed might 
trigger negative feedback that represses its proliferative 
activity. In contrast to proliferation, cell spreading, migra-
tion, and adhesion of BEL-7402/MR-1 cells were all signif-
icantly increased. Further, these activities were all de-
creased in response to MR-1 knockdown. These results 
confirm that MR-1 plays an important role in cell spreading, 
adhesion and migration in human hepatoma cells. 
Tumorigenesis and metastasis are related to numerous 
macromolecules with very complex interactions. We used a 
human genome oligonucleotide microarray to analyze glob-
al gene expression changes induced by MR-1 overexpres-
sion or knockdown. MR-1 expression regulates many bio-
logical processes, including cell proliferation, differentia-
tion, and migration.  
The regulation of MR-1 expression affected many genes 
related to cell proliferation, migration and invasion, includ-
ing MAPK, Wnt, and actin cytoskeleton regulatory proteins. 
One of the genes that was prominently upregulated in BEL- 
7402/MR-1 cells was fibronectin, FN1. FN1 mRNA levels 
were increased 17.7-fold and reduced 6.2-fold in MR-1 
knocked down cells. Fibronectin is an important extracellu-
lar matrix protein that promotes the tyrosine phosphoryla-
tion of paxillin and other focal adhesion proteins and can 
stimulate cancer cell invasion and metastasis [17]. FN1 is 
now used as a diagnostic marker for several kinds of cancer, 
such as thyroid cancer and malignant melanoma [18]. VAV2 
mRNA level in BEL-7402/MR-1 cells was increased by 
1.5-fold, and decreased by 5.6-fold in MR-1 knockdown 
cells. VAV2 is a guanine nucleotide exchange factor for Rho 
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GTPases and can inhibit the internalization and degradation 
of growth factor receptor. This stimulates the phosphoryla-
tion of EGFR, ERK and Akt and promotes growth fac-
tor-induced cell adhesion, migration, spreading and prolif-
eration [19]. Another gene with a similar regulation pattern 
was integrin 5 (ITGA5), a subunit of the 51 integrin that 
is a specific fibronectin receptor and mediates cell attach-
ment, migration, and proliferation in many cells [20]. SDC2 
expression was also regulated by MR-1 and can promote 
Tiam1-dependent Rac activation to promote migration of 
rectal cancer cells [21]. ARPC1A, a new tumor- related gene, 
was also affected by MR-1 expression levels. This is an 
actin-related protein and has been found to be an important 
regulator of cell motility and invasion is in pancreatic can-
cer cells [22,23]. Altogether, there were a number of im-
portant genes related to cell adhesion; invasion and spreading 
that were regulated by MR-1 expression. The regulation of 
these pathways might promote cancer cell invasion and me-
tastasis induced by MR-1 overexpression in tumors. 
For genes related to cell proliferation, MR-1 expression 
showed heterogeneous effects. On the one hand, MR-1 
overexpression up-regulated pathways that promotes cell 
growth, such as MAPK and Wnt signaling. On the other 
hand, MR-1 overexpression also increased the expression of 
cyclin-dependent kinase inhibitor 1C (p57) and reduced 
CCNB1 levels, which represses cell cycle signaling. These 
non-congruent effects may help explain why the overex-
pression of MR-1 in BEL-7402 cells showed no significant 
changes in cell proliferation. 
In summary, we have shown that MR-1 may be involved 
in and regulate tumor cell proliferation, adhesion and mi-
gration by regulating a number of signaling pathways in-
volved in these complex processes. Further research will 
need to clarify the role of MR-1 in these pathways, eluci-
date its upstream regulation, and identify its direct target 
genes. Together, this research should help clarify the role of 
MR-1 in cancer progression as well as its potential as a 
novel therapeutic target. 
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